Big Announcement Alert: Discoveries meet momentum. Right here.

Fitzsimon_menu

Innovation is happening. Right here.

Fitzsimons Innovation Community is a sprawling campus of leading-edge laboratory workspace where innovative health and life sciences companies of all sizes take their research to the next level to cure diseases, save lives, and improve care. Move in, and build your vision here—today.

Community

The emphasis is on Community

We called it a community for a reason. From the board of directors to the newest company on campus, everyone at Fitzsimons Innovation Community knows that easy access to collaboration has direct results on success. From idea incubation to final-product manufacturing, your end-to-end innovation can come alive right here on our campus. All that Colorado sunshine is just a bonus.

Community

Cutting-edge discoveries in action

91%

Companies Thriving

Fitzsimons Innovation Community member companies are thriving. 91% of companies reported either no change to workforce or added employees.

12+

Patents

Fitzsimons Innovation Community member companies received more than 12 patents for their innovations in 2021, a 50% increase over the prior year.

16+

New Innovations

Fitzsimons Innovation Community member companies introduced more than 16 new innovations to the market in 2021, from pharmaceuticals to molecular biology to medical devices.

$25M+

Capital Raised

In 2021, Fitzsimons Innovation Community member companies attracted more than $25M in investments to advance R&D, accelerate commercialization, support clinical trials, and fine-tune technology.

61%

Companies with Discoveries

Fitzsimons Innovation Community member companies made news with major breakthrough discoveries last year. Areas included pharmaceuticals, cell and gene therapy, medical devices, molecular biology, and diagnostics.

92%

Companies Satisfied

Fitzsimons Innovation Community member companies appreciate access to resources, opportunities to interact, proximity to research institutions, and the value offered by Community membership.

*Fitzsimons Innovation Community Member Growth Survey responses (January – December 2021)

A heritage of healthcare and innovation

Fitzsimons Innovation Community stands on the grounds that once held the Fitzsimons Army Hospital, where soldiers returning from World War I were treated. The Colorado high altitude has always been a destination for advancements in lung treatment, and 100 years ago, soldiers sought cures for tuberculosis and mustard gas exposure right here.

After the Army decommissioned the hospital in the 1990s, ideas for the current University of Colorado Anschutz Medical Campus and Fitzsimons Innovation Community began to percolate. That rich history of discovery, care, and research continues to inspire our vision a century later.

Our team is on your team

You know best when it comes to your projects, and we know how to keep you up and running with first-class scientific facilities management and community engagement. Our priority is to help you thrive on this campus and we have the proven tools and expertise to make that happen.

Ann Dennis

COMMUNITY SERVICE MANAGER

April Giles

Vp, business development

Don Larson

Facilities engineer

Erica N. Slaughenhoup

Accounting Specialist

Julie Ehler

Accounting Lead

Lyle Artz

Site manager

Mary Williams

Property administrator

Steve VanNurden

PRESIDENT & CEO

Sue Niblo

Senior property manager

Thomas Smith

Vp, finance & operations

“The workspace has been perfect for our projects, but the most impressive thing to me has been the community. We’ve collaborated with researchers from the CU Anschutz Medical Campus, networked with other Fitzsimons Innovation Community members, and bounced ideas off some of the best minds in healthcare. And it’s all contributed to us moving forward in our research.”

Scott Deeter

CEO, InVitria

“I park my car in the morning, and then I never move it until I leave after work. We walk to lunch and meetings and take advantage of the outdoor space as much as we can during the day. Work-life balance happens right on campus.”

Kristin Nixon

President, PhosphoSolutions

Community

Fitzsimons Innovation Community News

Fitzsimons Innovation Community Growing as Life Sciences Hub in Aurora
News | Jun 24, 2022

Fitzsimons Innovation Community Growing as Life Sciences Hub in Aurora

The plan calls for 45 thousand jobs at full buildout. Already there is a $10 Billion dollar annual economic impact in a single square mile....

US-Based Biotechnology Company, Taiga Launches Breakthrough Veterinary Cancer Treatment in Singapore
News | Apr 29, 2022

US-Based Biotechnology Company, Taiga Launches Breakthrough Veterinary Cancer Treatment in Singapore

Taiga Biotechnologies, a clinical-stage biotechnology company focused on harnessing the power of the immune system to fight solid tumors and infectious disease...

Fitzsimons Innovation Community Welcomes Four New Board Members
News | Apr 28, 2022

Fitzsimons Innovation Community Welcomes Four New Board Members

Comprised of leaders representing the bioscience industry, University of Colorado, and the City of Aurora, the Board of Directors supports the vision of Fitzsimons Innovation Community.

26 Top BioPharma Startups & Companies (Colorado)
News | Apr 25, 2022

26 Top BioPharma Startups & Companies (Colorado)

BioPharma companies have been making some huge strides over the last year with innovations driven by both established players and startups entering the scene. With an impressive 7.32% CAGR and a value of $325.17 billion in 2020 it is a huge industry ripe for growth.

Colorado Life Sciences Companies Raise a Record $2.4 Billion in 2021
News | Dec 14, 2021

Colorado Life Sciences Companies Raise a Record $2.4 Billion in 2021

Colorado’s life sciences ecosystem raised $2.4 billion in 2021, a new record for the fast-growing community that includes companies at all stages of commercialization and academic and research institutions. The 2021 fundraising total is double the $1.2 billion raised by the Colorado life sciences community in 2020. Sources of funding included headline-making IPOs, significant additional capital raised in public markets, an infusion of venture capital, and grants from federal and state sources.

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application
News | Nov 30, 2021

European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application

Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tabelecleucel (tab-cel®) has been fully validated by the European Medicines Agency (EMA).

Pathways Bioscience Seeks to Optimize Aging
News | Nov 30, 2021

Pathways Bioscience Seeks to Optimize Aging

Pathways Bioscience’s technology improves healthspan and overcomes health and wellness problems associated with aging.

Two CU Cancer Center Members Recognized as World Experts in Pancreatic Neoplasms
News | Nov 19, 2021

Two CU Cancer Center Members Recognized as World Experts in Pancreatic Neoplasms

Expertscape rankings recognize Richard Schulick, MD, and Marco Del Chiaro, MD, among the top 0.1% of scholars worldwide.

Want to stay on top of what’s happening on campus?

Sign up for regular updates from Fitzsimons Innovation Community.